PegBio Converts 101.70 Million Unlisted Shares into H Shares, Enlarging Hong Kong Free Float by 26%

Bulletin Express06-26

On 26 June 2026, PegBio Co., Ltd. (abbreviated as “PegBio”) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, confirming the conversion of 101.70 million unlisted shares into H shares. The conversion, completed on 25 June 2026, has immediate trading commencement on 26 June 2026.

Post-conversion, PegBio’s issued H shares expanded from 284.30 million to 386.00 million, marking a 26.00% increase in the Exchange-listed portion of its share capital. Correspondingly, the company’s unlisted share pool contracted from 106.79 million to 5.09 million.

Total issued share capital remains unchanged at 391.09 million shares; the transaction solely reclassified equity from unlisted to listed status and did not involve any new share issuance, treasury-share movement, repurchase or cancellation.

The conversion follows earlier announcements released on 28 November 2025 and 9 April 2026, and was fully authorised by the board, with all regulatory and listing rule requirements confirmed as satisfied.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1184250474?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-26 12:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184250474","market":"hk","top_or_hot":-1,"title":"PegBio Converts 101.70 Million Unlisted Shares into H Shares, Enlarging Hong Kong Free Float by 26%","media":"Bulletin Express","content":"<p>On 26 June 2026, PegBio Co., Ltd. (abbreviated as “PegBio”) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, confirming the conversion of 101.70 million unlisted shares into H shares. The conversion, completed on 25 June 2026, has immediate trading commencement on 26 June 2026.</p>\n<p>Post-conversion, PegBio’s issued H shares expanded from 284.30 million to 386.00 million, marking a 26.00% increase in the Exchange-listed portion of its share capital. Correspondingly, the company’s unlisted share pool contracted from 106.79 million to 5.09 million.</p>\n<p>Total issued share capital remains unchanged at 391.09 million shares; the transaction solely reclassified equity from unlisted to listed status and did not involve any new share issuance, treasury-share movement, repurchase or cancellation.</p>\n<p>The conversion follows earlier announcements released on 28 November 2025 and 9 April 2026, and was fully authorised by the board, with all regulatory and listing rule requirements confirmed as satisfied.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PegBio Converts 101.70 Million Unlisted Shares into H Shares, Enlarging Hong Kong Free Float by 26%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPegBio Converts 101.70 Million Unlisted Shares into H Shares, Enlarging Hong Kong Free Float by 26%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-26 12:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 26 June 2026, PegBio Co., Ltd. (abbreviated as “PegBio”) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, confirming the conversion of 101.70 million unlisted shares into H shares. The conversion, completed on 25 June 2026, has immediate trading commencement on 26 June 2026.</p>\n<p>Post-conversion, PegBio’s issued H shares expanded from 284.30 million to 386.00 million, marking a 26.00% increase in the Exchange-listed portion of its share capital. Correspondingly, the company’s unlisted share pool contracted from 106.79 million to 5.09 million.</p>\n<p>Total issued share capital remains unchanged at 391.09 million shares; the transaction solely reclassified equity from unlisted to listed status and did not involve any new share issuance, treasury-share movement, repurchase or cancellation.</p>\n<p>The conversion follows earlier announcements released on 28 November 2025 and 9 April 2026, and was fully authorised by the board, with all regulatory and listing rule requirements confirmed as satisfied.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02565","symbol_name":"派格生物医药-B","start_time":0,"source_url":"","article_id":"1184250474","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184250474","pubTimestamp":1782447837,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 26 June 2026, PegBio Co., Ltd. (abbreviated as “PegBio”) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, confirming the conversion of 101.70 million unlisted shares into H...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02565":"派格生物医药-B"},"translate_title":"培格生物将1.017亿股非上市股份转换为H股，香港自由流通量扩大26%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02565":1},"content_text":"On 26 June 2026, PegBio Co., Ltd. (abbreviated as “PegBio”) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, confirming the conversion of 101.70 million unlisted shares into H shares. The conversion, completed on 25 June 2026, has immediate trading commencement on 26 June 2026.\nPost-conversion, PegBio’s issued H shares expanded from 284.30 million to 386.00 million, marking a 26.00% increase in the Exchange-listed portion of its share capital. Correspondingly, the company’s unlisted share pool contracted from 106.79 million to 5.09 million.\nTotal issued share capital remains unchanged at 391.09 million shares; the transaction solely reclassified equity from unlisted to listed status and did not involve any new share issuance, treasury-share movement, repurchase or cancellation.\nThe conversion follows earlier announcements released on 28 November 2025 and 9 April 2026, and was fully authorised by the board, with all regulatory and listing rule requirements confirmed as satisfied.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1184250474","isCrawlerRequest":true}